Baker’s Yeast Clinical Isolates Provide a Model for How Pathogenic Yeasts Adapt to Stress

Publication date: Available online 13 September 2019Source: Trends in GeneticsAuthor(s): Vandana Raghavan, Charles F. Aquadro, Eric AlaniGlobal outbreaks of drug-resistant fungi such as Candida auris are thought to be due at least in part to excessive use of antifungal drugs. Baker’s yeast Saccharomyces cerevisiae has gained importance as an emerging opportunistic fungal pathogen that can cause infections in immunocompromised patients. Analyses of over 1000 S. cerevisiae isolates are providing rich resources to better understand how fungi can grow in human environments. A large percentage of clinical S. cerevisiae isolates are heterozygous across many nucleotide sites, and a significant proportion are of mixed ancestry and/or are aneuploid or polyploid. Such features potentially facilitate adaptation to new environments. These observations provide strong impetus for expanding genomic and molecular studies on clinical and wild isolates to understand the prevalence of genetic diversity and instability-generating mechanisms, and how they are selected for and maintained. Such work can also lead to the identification of new targets for antifungal drugs.
Source: Trends in Genetics - Category: Genetics & Stem Cells Source Type: research